São Paulo - Delayed Quote BRL

HCA Healthcare, Inc. (H1CA34.SA)

Compare
93.96 0.00 (0.00%)
At close: June 26 at 4:23 PM GMT-3
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
66,716,000.00
64,968,000.00
60,233,000.00
58,752,000.00
51,533,000.00
--
Cost of Revenue
10,150,000.00
9,902,000.00
9,371,000.00
9,481,000.00
8,369,000.00
--
Gross Profit
56,566,000.00
55,066,000.00
50,862,000.00
49,271,000.00
43,164,000.00
--
Operating Expense
46,813,000.00
45,439,000.00
41,809,000.00
39,593,000.00
35,902,000.00
--
Operating Income
9,753,000.00
9,627,000.00
9,053,000.00
9,678,000.00
7,262,000.00
--
Net Non Operating Interest Income Expense
-1,971,000.00
-1,938,000.00
-1,741,000.00
-1,566,000.00
-1,584,000.00
--
Other Income Expense
249,000.00
17,000.00
1,268,000.00
1,721,000.00
-248,000.00
--
Pretax Income
8,031,000.00
7,706,000.00
8,580,000.00
9,833,000.00
5,430,000.00
--
Tax Provision
1,681,000.00
1,615,000.00
1,746,000.00
2,112,000.00
1,043,000.00
--
Net Income Common Stockholders
5,470,000.00
5,242,000.00
5,643,000.00
6,956,000.00
3,754,000.00
--
Diluted NI Available to Com Stockholders
5,470,000.00
5,242,000.00
5,643,000.00
6,956,000.00
3,754,000.00
--
Basic EPS
1.02
0.96
0.97
1.14
0.55
--
Diluted EPS
1.00
0.95
0.96
1.06
0.55
--
Basic Average Shares
5,385,705.00
5,448,080.00
5,806,960.00
6,109,536.00
6,788,512.00
--
Diluted Average Shares
5,463,515.00
5,528,240.00
5,893,320.00
6,575,040.00
6,872,100.00
--
Total Expenses
56,963,000.00
55,341,000.00
51,180,000.00
49,074,000.00
44,271,000.00
--
Net Income from Continuing & Discontinued Operation
5,470,000.00
5,242,000.00
5,643,000.00
6,956,000.00
3,754,000.00
--
Normalized Income
5,303,165.23
5,245,950.00
4,668,269.00
5,693,720.00
3,998,016.00
--
Interest Expense
1,971,000.00
1,938,000.00
1,741,000.00
1,566,000.00
1,584,000.00
--
Net Interest Income
-1,971,000.00
-1,938,000.00
-1,741,000.00
-1,566,000.00
-1,584,000.00
--
EBIT
10,002,000.00
9,644,000.00
10,321,000.00
11,399,000.00
7,014,000.00
--
EBITDA
13,118,000.00
12,721,000.00
13,290,000.00
14,252,000.00
9,735,000.00
--
Reconciled Cost of Revenue
10,150,000.00
9,902,000.00
9,371,000.00
9,481,000.00
8,369,000.00
--
Reconciled Depreciation
3,116,000.00
3,077,000.00
2,969,000.00
2,853,000.00
2,721,000.00
--
Net Income from Continuing Operation Net Minority Interest
5,470,000.00
5,242,000.00
5,643,000.00
6,956,000.00
3,754,000.00
--
Total Unusual Items Excluding Goodwill
211,000.00
-5,000.00
1,223,000.00
1,608,000.00
-302,000.00
--
Total Unusual Items
211,000.00
-5,000.00
1,223,000.00
1,608,000.00
-302,000.00
--
Normalized EBITDA
12,907,000.00
12,726,000.00
12,067,000.00
12,644,000.00
10,037,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
44,165.23
-1,050.00
248,269.00
345,720.00
-57,984.00
--
12/31/2019 - 2/18/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade